Lauren McLaughlin

Lauren McLaughlin (MacMullen) is an experienced professional in clinical operations and trial management, currently serving as Associate Director, Clinical Operations at Obsidian Therapeutics since July 2023. Previously, Lauren held significant roles including Senior Clinical Trial Manager and Clinical Trial Manager at TCR² Therapeutics Inc. from May 2019 to July 2023, where responsibilities included managing study-specific documents and FDA inspection readiness activities. Earlier experience includes a position as Clinical Trial Associate at Karyopharm Therapeutics Inc., Project Manager-Health Science Specialist at the U.S. Department of Veterans Affairs, and Clinical Research Coordinator at Tufts Medical Center, focusing on critical care medicine. Academic credentials include a Bachelor’s Degree in Human Physiology from Boston University and a Master of Science in Project Leadership and Management from Regis University.